1247734-91-3Relevant academic research and scientific papers
2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression
Carter, David S.,Cai, Hai-Ying,Lee, Eun Kyung,Iyer, Pravin S.,Lucas, Matthew C.,Roetz, Ralf,Schoenfeld, Ryan C.,Weikert, Robert J.
scheme or table, p. 3941 - 3945 (2010/09/03)
Recently a class of compounds known as triple reuptake inhibitors has emerged as a new strategy for the treatment of depression. These compounds work by simultaneously inhibiting the synaptic reuptake of serotonin, norepinephrine and dopamine. In this Let
